Quality Control

  • Shcherbik Lab

Quality Control

Quality Control

What are the mechanisms of ribosome degradation and ribosome surveillance?

The process of ribosome biogenesis is well studied, but the mechanisms underlying ribosome degradation are still poorly defined. As of today, two major pathways of ribosome decay have been described: non-functional ribosome decay (NRD), which eliminates defective ribosomes; and ribophagy, a form of autophagy that removes ribosomes in bulk upon starvation.

In our lab, we explore additional models of ribosome degradation that allow cells to recognize and remove old ribosomes and maintain a healthy ribosome pool, important for error-free translation and successful adaptation to a constantly changing environment. We have found that the E3 ubiquitin ligase Rsp5 is required for rRNA integrity by ubiquitinating ribosomal proteins on functional ribosomes (Shcherbik 2011). We have also demonstrated that suppressing TOR signaling induces a distinct cytoplasmic form of ribosome degradation in yeast (Pestov 2012). Both Rsp5-dependent and rapamycin-induced cytoplasmic turnover of ribosomes involves nucleases and is mechanistically distinct from ribophagy and NRD (Pestov 2012). Finally, we discovered a novel ribosome surveillance pathway, translational re-localization with aberrant polypeptides (TRAP), which operates on ribosomes during proteotoxic stress by sequestering ribosome-nascent chain complexes into perinuclear compartments (JUNQ) shared with misfolded proteins (Ghosh et al., 2020). We propose that TRAP represents a cellular strategy to maintain healthy protein homeostasis.

Future studies. To know more about TRAP, we are interested in addressing the following questions:

  • What additional molecular factors operate within the TRAP pathway?
  • Are TRAPed ribosomes released from JUNQ to participate in a new round of translation, or do they undergo degradation? In the latter case, what are the mechanism(s) that mediate degradation of faulty TRAPed ribosomes?
  • What molecular aberrations (within mRNA or nascent polypeptide chains) activate TRAP?